Physician profile
Patrick M Gill
NPI 1801232103
$5,102.48
in general payments reported to CMS, 2019-2025
41 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $116 · 2021: $286 · 2022: $1,110 · 2023: $1,302 · 2024: $953 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,441.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $885.21 | 2021-2025 | |
| Novo Nordisk INC | $814.62 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $707.83 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $415.82 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $224.38 | 2023-2025 | |
| Astellas Pharma US INC | $221.67 | 2023-2025 | Veozah, Myrbetriq, Vesicare |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.22 | 2020-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $145.12 | 2022-2025 | |
| Amgen INC. | $142.14 | 2019-2025 | Otezla, Repatha, Repatha |
| Abbott Laboratories | $134.23 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $132.30 | 2022 | |
| Exact Sciences Corporation | $119.25 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $105.31 | 2019-2024 | Injectafer |
| Glaxosmithkline, LLC. | $94.83 | 2022-2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.01 | 2019-2024 | Jardiance |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.